MBLAC1 and Parkinson disease: Based on previous research [22], [23], [24], [25], pharmacological treatments that restore normal metabolic function via manipulation of Mblac1 pathways may be of benefit in the treatment of neurodegenerative disorders, including AD and Parkinson’s disease.